Oleptiss 360 mg Tablet 30's
About Oleptiss 360 mg Tablet 30's
Oleptiss 360 mg Tablet 30's belongs to the group of medicines called iron chelators. Oleptiss 360 mg Tablet 30's is indicated for treating chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients two years older. It can also be indicated for treating chronic iron overload in patients ten years of age and older with non-transfusion-dependent thalassemia (NTDT).
The active ingredient in Oleptiss 360 mg Tablet 30's is deferasirox. It is a trivalent iron selective chelating agent. It binds the excess iron and eliminates it through faeces. The danger of organ damage is reduced as a result.
Oleptiss 360 mg Tablet 30's is available in the form of oral formulations. Please take Oleptiss 360 mg Tablet 30's in the dose and duration prescribed by your doctor based on specific medical conditions. In some cases, you may experience common side effects such as diarrhoea, vomiting, nausea, abdominal pain, skin rashes, and increased serum creatinine. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
To treat your condition effectually, continue using Oleptiss 360 mg Tablet 30's for as long as your doctor has prescribed it. Do not use Oleptiss 360 mg Tablet 30's without a doctor's advice if you have a skin reaction or irritation to any medicine. Consult your doctor before using the Oleptiss 360 mg Tablet 30's if you are pregnant or breastfeeding. Do not use Oleptiss 360 mg Tablet 30's in more than prescribed doses or longer duration as it may cause adverse effects. Keep your doctor informed about your health condition and all the medicines you take before taking Oleptiss 360 mg Tablet 30's to rule out any side effects.
Uses of Oleptiss 360 mg Tablet 30's
Medicinal Benefits
Deferasirox is the active component in Oleptiss 360 mg Tablet 30's. It's a chelating agent that selectively binds to trivalent iron. It binds extra iron and excretes it in the faeces. As a result, the risk of organ damage is lowered.
Directions for Use
Storage
Side Effects of Oleptiss 360 mg Tablet 30's
Drug Warnings
Do not take Oleptiss 360 mg Tablet 30's if you are allergic to Oleptiss 360 mg Tablet 30's or its ingredients. Oleptiss 360 mg Tablet 30's is not usually recommended if you are a pregnant or lactating woman; there is not enough information to say whether it's safe. However, your doctor may prescribe it if they think the medicine's benefits outweigh the risks. It is unknown whether Oleptiss 360 mg Tablet 30's alters the ability to drive, so do not drive or operate machinery if you experience any symptoms affecting your ability to concentrate and react. Seek medical attention if the symptoms persist longer. Avoid consuming alcohol along with Oleptiss 360 mg Tablet 30's as it could lead to unpleasant side effects. Should monitor elderly and paediatric patients closely for toxicity.
Drug Interactions
Drug-Drug interactions: Oleptiss 360 mg Tablet 30's may interact with aluminium-containing antacids (e.g. aluminium hydroxide, aluminium glycinate), anti-diabetic drugs (e.g. repaglinide), xanthines (e.g. theophylline), alkylating agents (e.g. busulfan), nonsteroidal anti-inflammatory drugs (e.g. aspirin, celecoxib) and antihypertensive drugs (e.g. diltiazem), and common painkiller (e.g. paracetamol).
Drug-Food Interactions: Avoid consuming alcohol and caffeine along with Oleptiss 360 mg Tablet 30's.
Drug-Disease Interactions: People affected with bone marrow suppression, dermatologic toxicities, hepatic impairment, renal dysfunction, auditory and ocular abnormalities, and GI complication should consult the doctor before taking Oleptiss 360 mg Tablet 30's.
Drug-Drug Interactions Checker List
Habit Forming
Diet & Lifestyle Advise
Special Advise
Disease/Condition Glossary
Hemochromatosis, or iron overload, is a condition in which your body stores too much iron. It can cause severe damage to your body, including to your heart, liver and pancreas.